Chemours Company EBIT

Chemours Company posts a EBIT of $-700M as of June 2026. That compares with $-93M in the prior-year period — down 649.5% year over year. That is below the Consumer Discretionary sector average of $150B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Chemours Company's EBIT was $-93M. The latest reading is $-700M — a 649.5% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Consumer Discretionary stocks, a EBIT near $150B is typical. Chemours Company's $-700M is lower that level. That is roughly 100.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Chemours Company's financial statement story. At $-700M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CC's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $150B), and (3) consistency with growth and profitability. This page covers the first two; Chemours Company's other metric pages and overview cover the third.